Avient, a US-based multinational specialized polymer materials manufacturer, has agreed to sell its distribution business to an affiliate of private equity group H.I.G. Capital for $950 million in cash.
The strategic partnership of Boston-based US biotech GreenLight Biosciences and Korean CDMO Samsung Biologics has completed the first commercial-scale engineering run for its mRNA production.
Both houses of the US Congress have passed the White House’s $430 billion bill, which could decisively shape issues as diverse as pharmaceutical pricing and greenhouse gas emissions.
Japan’s Kao Corp. is planning to double capacity of synthetic fragrance methyl dihydrojasmonate (MDJ) at its plant in Spain as it aims to expand market share in Europe for the jasmine-scented product.
Johnson & Johnson is finally pulling the plug on its iconic talc-based baby powder worldwide.
Mitsubishi Chemical is planning to increase production of its Soarnol ethylene vinyl alcohol copolymer (EVOH) resin at Saltend in the UK.
US specialty chemicals company Solenis has entered into an agreement to buy Clearon, a compatriot manufacturer of sanitizers and disinfectants for water treatment and household, industrial and institutional applications. Financial terms of the deal were not disclosed.
A US federal court has ordered Eli Lilly to pay over $61 million in damages after whistleblower Ronald Streck filed a lawsuit alleging that the drugmaker had underpaid rebates required under the Medicaid program.
German engineering plastics producer Covestro has signed a definitive agreement to sell its Additive Manufacturing Business to US 3D printing specialist Stratasys for about €43 million. Closing of the deal is expected for the first quarter of 2023.
Göttingen, Germany-based life science group Sartorius, through its French-listed subgroup Sartorius Stedim Biotech, plans to acquire all shares of Nottingham, England’s Albumedix, a specialist in recombinant albumin-based solutions, for about £415 million.
American Australian engineering group Worley has won two contracts from Corpus Christi Polymers (CCP) to build an integrated PTA/PET plant in Corpus Christi, Texas, USA.
Borealis has confirmed its intention to launch a squeeze-out offer for Belgian fertilizer producer Rosier. It already held 77.5% of Rosier and raised its shareholding to 98.09% through a capital increase late last month.
CDMO heavyweight Catalent is acquiring compatriot Metrics Contract Services, a full-service specialty CDMO with a facility in Greenville, North Carolina, for $475 million. Mayne Pharma Group is the seller.
As one of the BASF group’s latest steps to increase sustainability and move closer to net zero emissions, US subsidiary BASF Corporation is embracing one of the newest instruments popular with US industry, virtual power purchase agreements (VPPAs).
British multinational engineering and consulting group Wood has won a contract worth more than $100 million to provide engineering and construction management services to Ineos’ proposed cracker complex in Antwerp, Belgium.
Thermo Fisher Scientific has completed the planned expansion of its US dry powder media manufacturing capacity in Grand Island, New York, which it said is designed to meet increasing global demand for cell culture media used in the manufacturing of new vaccines and biologics.
Italy’s Stamicarbon, part of engineering group Maire Tecnimont, has been selected to license its urea technology for a project in Sub-Saharan Africa. The melt and granulation plant, the first urea production facility in the country, will have capacity of 4,000 t/d. The identity of the client was not disclosed.
Gilead Sciences has agreed to acquire MiroBio, a privately held UK biotech focused on treating inflammatory diseases, for about $405 million in cash.
Borealis has reaffirmed the suspension of construction on a new propane dehydrogenation (PDH) plant at Kallo, Belgium. The Vienna-based group cited “serious allegations” concerning a two-subcontractor joint venture that is being scrutinized by Belgian authorities.
Amgen is beefing up its inflammatory diseases portfolio with an agreement to buy US biopharma ChemoCentryx for roughly $3.7 billion. The deal gives Amgen access to vasculitis treatment Tavneos.
Pfizer is paying $5.4 billion to acquire Global Blood Therapeutics (GBT), a drugmaker specialized in treating blood disorders. It is one of several deals the company has inked recently to offset dwindling sales from its vaccine and therapeutics for Covid-19.
In addition to the transformation towards a climate-neutral chemical industry and the perennial topic of digitalization, the current global political situation also poses massive challenges for the process industry. Which technologies can be used to achieve defossilization? How to secure and enhance regional and global supply chain networks? And what hurdles must be overcome in the digitalization of the industry?
Engineering companies McDermott International and KBR have entered into a global licensing agreement to provide integrated solutions for KBR's proprietary ammonia technologies.
A recession is headed for Europe that will be deeper and last longer than the financial crisis of 2008, Markus Steilemann, CEO of engineering plastics producer Covestro, predicted in an interview with a German business newspaper.
French biopharma Ipsen and US-based Marengo Therapeutics have formed a strategic partnership that aims to advance two of Marengo’s preclinical immuno-oncology candidates.
Following up on expansion plans hinted at last year, Germany’s Wacker Chemie is proposing to build up its US complex at Charleston, Tennessee, into a center for silicone specialties.
The consolidation in the distribution sector continues. In the latest deal, Life Sciences distributor Barentz International has announced the acquisition of Volp Indústria e Comércio, a Brazilian distributor of supplies and solutions for the Personal Care sector.
Saudi Aramco and Sinopec have signed a Memorandum of Understanding (MoU) that covers multiple areas of potential collaboration in Saudi Arabia.
Univar Solutions has bought Vicom Distribución Productos Quimicos, a specialty chemicals distributor operating in Spain and Portugal, in its first acquisition of the year.
Cariflex, a subsidiary of South Korea’s DL Chemical, has started building a polyisoprene latex plant on Jurong Island, Singapore. The plant, which Cariflex said will be the world’s largest and the first in Singapore for this type of latex, is expected to be operational by the second half of 2024.
Australian biopharma CSL said this week it has received all the regulatory clearance required to take over Switzerland’s Vifor. The acquisition announced in December 2021 temporarily stalled in May 2022.
In its drive to become a climate-neutral company, Germany-based oxo-chemicals specialist OQ Chemical has announced it will switch all of its worldwide production sites to run on electricity from renewable sources in the medium term.
Chemours is expanding capacity for its Opteon YF refrigerants to meet customer demand. The Delaware-headquartered US group described the $80 million project at Corpus Christi, Texas, as a “critical growth investment.”
Pfizer and BioNTech are fighting back against CureVac’s lawsuit that asserts the makers of the Comirnaty-branded mRNA vaccine for Covid-19 infringed its patent.
Thai-headquartered petrochemicals and polyester giant Indorama Ventures (IVL) and Capchem USA, a subsidiary of China’s Shenzhen Capchem Technology, are reviewing options for jointly building and operating a carbonate plant to supply the North American lithium-ion battery market.
